Newbury Pharmaceuticals AB
ISIN: SE0015244884 | Ticker: NEWBRY | LEI: 549300F7XHU3I8CWL373
Country: Sweden
2020
HeadquartersScheeletorget 1, 223 81 Lund – Sweden
| Date | Trading entity / Person | Association | Trade type | Volume |
|---|---|---|---|---|
| 14.04.23 | ANIL OKAY | Other | Buy | SEK 96,690.00 |
| 12.04.23 | Alsakali Equity AB | Other | Buy | SEK 26,420.00 |
| 10.02.23 | Andreas Hedskog | Other | Sell | SEK 550,000.00 |
| 10.02.23 | Hedskog Equity AB | Other | Buy | SEK 550,000.00 |
| 19.01.23 | Karl Karlsson | Other | Buy | SEK 61,900.00 |
| 17.01.23 | Andrea Karnitschky | Other | Buy | EUR 5,400.00 |
| 07.09.22 | Karl Karlsson | Other | Buy | SEK 103,050.00 |
| 06.09.22 | karl karlsson | Other | Buy | SEK 40,200.00 |
| 06.09.22 | Lars Minor | Other | Buy | SEK 28,010.50 |
| 06.09.22 | Andrea Karnitschky | Other | Buy | EUR 3,900.00 |
SE0015244884
LEI549300F7XHU3I8CWL373
Keep yourself informed with the most recent updates on FinancialReports, IPOs, product advancements, and other significant news.